阿拉丁跌2.02%，成交额3539.96万元，主力资金净流出337.76万元

Core Viewpoint - Aladdin's stock has experienced a decline of 2.02% on October 14, with a current price of 12.63 CNY per share, reflecting a total market capitalization of 4.201 billion CNY. The company has seen a year-to-date stock price increase of 11.44%, but has faced recent declines over various trading periods [1][2]. Financial Performance - For the first half of 2025, Aladdin reported a revenue of 275 million CNY, representing a year-on-year growth of 15.45%. However, the net profit attributable to shareholders decreased by 39.79% to 28.4635 million CNY [2]. - Cumulative cash dividends since the A-share listing amount to 241 million CNY, with 150 million CNY distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders increased by 22.88% to 12,500, while the average circulating shares per person decreased by 2.42% to 26,670 shares [2]. - Among the top ten circulating shareholders, notable changes include a decrease in holdings by China Europe Medical Health Mixed A and an increase by China Europe Responsibility Investment Mixed A [3]. Company Overview - Aladdin Biochemical Technology Co., Ltd. was established on March 16, 2009, and went public on October 26, 2020. The company specializes in the research, development, production, and sales of reagents, with 96.96% of its revenue coming from scientific research reagents [1]. - The company operates within the basic chemical industry, specifically in the chemical products sector, and is associated with various concepts including ursodeoxycholic acid and synthetic biology [1].